Immunic, Inc. (NASDAQ:IMUX) Q3 2024 Earnings Call Transcript
Operator: Good morning, and welcome to Immunic’s Third Quarter 2024 Earnings Call. My name is Jessica Breu, Vice President, Investor Relations and Communications at Immunic.
Immunic Inc. (IMUX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Quantamental Technologies Ran Pang | 0 | $0 | -100% | 0% |
| 2. | AQR Capital Management Cliff Asness | 0 | $0 | -100% | 0% |
| 3. | 0 | $0 | -100% | 0% | |
| 4. | Citadel Investment Group Ken Griffin | 0 | $0 | -100% | 0% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.15 | 87,300 | Director | 87,300 | 2024-11-12 | Filing | |
| $1.31 | 14,000 | Officer, Director | 390,877 | 2024-02-26 | Filing | |
| $1.75 | 5,000 | Officer | 25,510 | 2023-05-15 | Filing | |
| $1.26 | 47,000 | Director | 100,000 | 2022-12-14 | Filing | |
| $1.25 | 35,000 | Director | 53,000 | 2022-12-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.62 | 650 | Officer | 278,830 | 2020-07-21 | Filing | |
| $14.44 | 5,000 | Officer | 279,480 | 2020-07-20 | Filing | |
| $15.62 | 1,300 | Officer, Director | 362,877 | 2020-07-21 | Filing | |
| $14.44 | 5,000 | Officer, Director | 364,177 | 2020-07-20 | Filing | |
| $6.96 | 4,400 | Director | 10,032 | 2019-12-04 | Filing |
Institutional Investors' Holdings
News See All
Immunic, Inc. (NASDAQ:IMUX) Q1 2024 Earnings Call Transcript
Jessica Breu: Good morning, and welcome to Immunic First Quarter 2024 Earnings Call. My name is Jessica Breu, Vice President, Investor Relations and Communications here at Immunic.
Immunic, Inc. (NASDAQ:IMUX) Q4 2023 Earnings Call Transcript
Immunic, Inc. beats earnings expectations. Reported EPS is $-0.48, expectations were $-0.51.
Immunic, Inc. (NASDAQ:IMUX) Q2 2023 Earnings Call Transcript
Operator: Good morning, and welcome to Immunic's Second Quarter 2023 Earnings Call. My name is Jessica Breu, Head of Investor Relations and Communications at Immunic.
10 Best Rated Penny Stocks to Buy According to Analysts
Investing in small companies, penny stocks, micro-cap or even small-cap companies went out of fashion as soon as the financial markets started to take a beating amid interest rate hikes.
Immunic, Inc. (NASDAQ:IMUX) Q1 2023 Earnings Call Transcript
Jessica Breu: Good morning, and welcome to Immunic's First Quarter 2023 Earnings Call. My name is Jessica Breu, Head of Investor Relations and Communications at Immunic.
Immunic, Inc. (NASDAQ:IMUX) Q4 2022 Earnings Call Transcript
Jessica Breu: Good morning and welcome to Immunic's Fourth Quarter and Year End 2022 Earnings Call. My name is Jessica Breu, Head of Investor Relations and Communications at Immunic.
5 Popular Penny Stocks On Robinhood
In this article, we will discuss the 5 best penny stocks trending on Robinhood. If you want to explore similar stocks, you can read 11 Popular Penny Stocks On Robinhood.
5 Best Penny Stocks to Buy in July
Allbirds, Inc. (NASDAQ:BIRD) is based in San Francisco, California, where it manufactures footwear and apparel for men and women. On June 27, Allbirds, Inc.
Billionaire Hedge Funds
